Sagent Pharmaceuticals Announces U.S. FDA Approval of Bupivacaine Hydrochloride Injection, USP
SCHAUMBURG, Ill. -- Sagent Pharmaceuticals, Inc. today announced U.S. FDA approval of Bupivacaine Hydrochloride Injection, USP, a local or regional anesthetic. Sagent's bupivacaine will be available in ...

Chinese Food Exports Facing 3 Major Changes and New Challenges in the U.S., Says Benjamin England
According to Benjamin England, Chinese companies are facing 3 distinct challenges as they export product to the United States: Quality Control, FDA regulatory complexity and the increased role of third parties.Columbia, MD (PRWEB) October 18, 2011 As this year s China Seafood And Fisheries Expo approaches, industry leaders are preparing to tackle emerging food import issues and discuss how ...

Raptor Pharmaceutical Corp. Holds Pre-NDA Meeting With FDA for RP103 for Nephropathic Cystinosis
Raptor Pharmaceutical Corp. Holds Pre-NDA Meeting With FDA for RP103 for Nephropathic Cystinosis Raptor Pharmaceutical Corp. 25.10.2011 20:27 ----------------------------------------------...